CMS has posted updated guidance to Part D drug plan sponsors on a variety of issues, including CY 2011 Formulary Updates, Exclusion of Part D Payment for Drugs Included in the End-Stage Renal Disease Prospective Payment, Final Medicare Part D Reporting Requirements for Contract Year 2011, and Lessons Learned from the Medicare Part C and Part D Reporting Requirements.